sr141716 has been researched along with Apnea, Obstructive Sleep in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dou, ZJ; Hu, ZX; Liu, T; Wang, B; Wang, MT; Zhao, L | 1 |
Cui, F; Wang, X; Yu, Q; Yue, H; Zeng, S | 1 |
Al-Zaman, Y; Aylwin, S | 1 |
1 review(s) available for sr141716 and Apnea, Obstructive Sleep
Article | Year |
---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
2 other study(ies) available for sr141716 and Apnea, Obstructive Sleep
Article | Year |
---|---|
CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats.
Topics: Animals; Disease Models, Animal; Hypoxia; Kidney Tubules; Male; Membrane Proteins; Mitochondria; Mitochondrial Proteins; Random Allocation; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Renal Insufficiency, Chronic; Rimonabant; Sleep Apnea, Obstructive; Src Homology 2 Domain-Containing, Transforming Protein 1 | 2021 |
Effect of Intermittent Hypoxia and Rimonabant on Glucose Metabolism in Rats: Involvement of Expression of GLUT4 in Skeletal Muscle.
Topics: Animals; Blood Glucose; Cannabinoid Receptor Antagonists; Gene Expression Regulation; Glucose; Glucose Transporter Type 4; Hypoxia; Immunohistochemistry; Insulin Resistance; Male; Muscle, Skeletal; Piperidines; Pyrazoles; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Sleep Apnea, Obstructive | 2015 |